bexepril 5 mg film-coat. tabl.
chanelle pharm. man. ltd. - benazepril hydrochloride 5 mg - eq. benazepril 4,6 mg - film-coated tablet - 5 mg - benazepril hydrochloride 5 mg - benazepril - dog
bexepril 20 mg film-coat. tabl.
chanelle pharm. man. ltd. - benazepril hydrochloride 20 mg - eq. benazepril 18,42 mg - film-coated tablet - 20 mg - benazepril hydrochloride 20 mg - benazepril - dog
benazemav flavoured 20mg tablets for dogs
chanelle pharmaceuticals manufacturing limited - benazepril hydrochloride - oral tablet - benazepril hydrochloride ungrouped active 20.0 mg/tb - cardiovascular system
benazemav flavoured 2.5mg tablets for dogs
chanelle pharmaceuticals manufacturing limited - benazepril hydrochloride - oral tablet - benazepril hydrochloride ungrouped active 2.5 mg/tb - cardiovascular system
benazemav flavoured 5mg tablets for dogs
chanelle pharmaceuticals manufacturing limited - benazepril hydrochloride - oral tablet - benazepril hydrochloride ungrouped active 5.0 mg/tb - cardiovascular system
bexepril 20mg film-coated tablet for dogs
chanelle pharmaceuticals manufacturing ltd - benazepril hydrochloride - film-coated tablet - cardio vascular ace inhibitor - dogs
bexepril 2.5mg film-coated tablet for dogs
chanelle pharmaceuticals manufacturing ltd - benazepril hydrochloride - film-coated tablet - cardio vascular ace inhibitor - dogs
moexipril hydrochloride tablet film coated
avera mckennan hospital - moexipril hydrochloride (unii: q1umg3uh45) (moexiprilat - unii:h3753190js) - moexipril hydrochloride 7.5 mg
moexipril hydrochloride and hydrochlorothiazide tablets usp rx only
avkare, inc. - moexipril hydrochloride (unii: q1umg3uh45) (moexiprilat - unii:h3753190js), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - moexipril hydrochloride 7.5 mg - moexipril hydrochloride and hydrochlorothiazide tablets usp are indicated for treatment of patients with hypertension. this fixed combination is not indicated for the initial therapy of hypertension (see dosage and administration). in using moexipril hydrochloride and hydrochlorothiazide tablets usp, consideration should be given to the fact that another ace inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that moexipril hydrochloride and hydrochlorothiazide tablets usp do not have a similar risk (see warnings , neutropenia/agranulocytosis ). in addition, ace inhibitors, for which adequate data are available, cause a higher rate of angioedema in black than in nonblack patients (see warnings , angioedema ). moexipril hydrochloride and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitiv
univasc- moexipril hydrochloride tablet, film coated
ucb, inc. - moexipril hydrochloride (unii: q1umg3uh45) (moexiprilat - unii:h3753190js) - moexipril hydrochloride 7.5 mg - univasc ® is indicated for treatment of patients with hypertension. it may be used alone or in combination with thiazide diuretics. in using univasc ® , consideration should be given to the fact that another ace inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that univasc ® does not have a similar risk (see warnings). in considering use of univasc ® , it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. in addition, ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see warnings, angioedema). univasc ® is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatme